Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Body Mass on Filgrastim Pharmacokinetics

NCT01719432 is registered in ClinicalTrials.gov with Aaron Cumpston, PharmD, BCOP as lead sponsor.

NCT NCT01719432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01719432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Body Mass on Filgrastim Pharmacokinetics
Lead sponsor
Aaron Cumpston, PharmD, BCOP
Phase
Observational
Overall status
Completed
Start date
December 5, 2012
Completion date
December 31, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancy, neutropenia